Novartis posts a win, Roche a flop in skin cancer trials

ZURICH/MADRID, Sept 11 (Reuters) – Swiss drugmaker Novartisnotched a trial win for its drug cocktail against skincancer on Monday, while a rival treatment from Rochewith slipping sales failed in a separate study with a similarpatient group.
The post Novartis posts a win, Roche a flop in skin cancer trials appeared first on RocketNews | Top News Stories From Around the Globe.